Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lehr

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The AAPS Journal|May 24, 2014
Statistical comparison of dissolution profiles to predict the bioequivalence of extended release formulationsJ D Gomez-Mantilla, U F Schaefer, V G Casabo, et al.
European Journal of Pharmacology|May 4, 1984
Comparative study of the effects of salinomycin and monensin on electrophysiologic and contractile properties of canine myocardiumM S Gaide, J T Lehr, S S Wong, et al.
British Journal of Pharmacology|November 6, 2007
Contribution of the active metabolite M1 to the pharmacological activity of tesofensine in vivo: a pharmacokinetic-pharmacodynamic modelling approachT Lehr, A Staab, C Tillmann, et al.
Journal of Thrombosis and Haemostasis : JTH|October 7, 2011
Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trialK-H Liesenfeld, T Lehr, C Dansirikul, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The AAPS Journal|May 24, 2014
Statistical comparison of dissolution profiles to predict the bioequivalence of extended release formulationsJ D Gomez-Mantilla, U F Schaefer, V G Casabo, et al.
European Journal of Pharmacology|May 4, 1984
Comparative study of the effects of salinomycin and monensin on electrophysiologic and contractile properties of canine myocardiumM S Gaide, J T Lehr, S S Wong, et al.
British Journal of Pharmacology|November 6, 2007
Contribution of the active metabolite M1 to the pharmacological activity of tesofensine in vivo: a pharmacokinetic-pharmacodynamic modelling approachT Lehr, A Staab, C Tillmann, et al.
Journal of Thrombosis and Haemostasis : JTH|October 7, 2011
Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trialK-H Liesenfeld, T Lehr, C Dansirikul, et al.
Pageof 2